Synapse

← Multiple Sclerosis International

Papers in Multiple Sclerosis International

Page 1 · newest first

  1. Incongruence between Cardiorespiratory Fitness and Subjective Reports of Physical Activity in Multiple Sclerosis: A Focus on Sex DifferencesMultiple Sclerosis International · 2024
  2. White Matter Lesion Volumes on 3‐T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 YearsMultiple Sclerosis International · 2024
  3. Pulp Sensitivity Testing in Multiple Sclerosis: Disease Duration and Sensory/Motor Associations—A Cross‐Sectional StudyMultiple Sclerosis International · 2024
  4. Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple SclerosisMultiple Sclerosis International · 2023
  5. Cognitive Contributors of Backward Walking in Persons with Multiple SclerosisMultiple Sclerosis International · 2023
  6. Patient and Clinician Perspectives of Physical Therapy for Walking Difficulties in Multiple SclerosisMultiple Sclerosis International · 2023
  7. Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-AnalysisMultiple Sclerosis International · 2022
  8. The Effectiveness of Physiotherapy Interventions for Mobility in Severe Multiple Sclerosis: A Systematic Review and Meta-AnalysisMultiple Sclerosis International · 2022
  9. Disability and Fatigue in Multiple Sclerosis: Can Rehabilitation Improve Them through a Structured Retraining Program?Multiple Sclerosis International · 2022
  10. Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern SwedenMultiple Sclerosis International · 2022
  11. Telehealth-Delivered Cognitive Behavioral Therapy for Insomnia in Individuals with Multiple Sclerosis: A Pilot StudyMultiple Sclerosis International · 2022
  12. Prevalence of Pediatric Onset Multiple Sclerosis in Saudi ArabiaMultiple Sclerosis International · 2021
  13. Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used AssayMultiple Sclerosis International · 2021
  14. A Tripartite Knowledge Translation Program: Innovative Patient-Centered Approach to Clinical Research Participation for Individuals with Multiple SclerosisMultiple Sclerosis International · 2021
  15. Quantitative Magnetic Resonance Imaging Analysis of Early Markers of Upper Cervical Cord Atrophy in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderMultiple Sclerosis International · 2021
  16. A Descriptive Correlational Study to Evaluate Three Measures of Assessing Upper Extremity Function in Individuals with Multiple SclerosisMultiple Sclerosis International · 2021
  17. State-of-the-Art Review: Demyelinating Diseases in IndonesiaMultiple Sclerosis International · 2021
  18. Pulmonary Function and Respiratory Muscle Strength in Patients with Multiple SclerosisMultiple Sclerosis International · 2021
  19. Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)Multiple Sclerosis International · 2021
  20. Speed but Not Smoothness of Gait Reacts to Rehabilitation in Multiple SclerosisMultiple Sclerosis International · 2021
  21. Risk Factors Associated with Multiple Sclerosis: A Case-Control Study in Damascus, SyriaMultiple Sclerosis International · 2021
  22. No Early Effect of Intrathecal Rituximab in Progressive Multiple Sclerosis (EFFRITE Clinical Trial)Multiple Sclerosis International · 2021
  23. A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1aMultiple Sclerosis International · 2021
  24. Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert ConsensusMultiple Sclerosis International · 2021
  25. The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple SclerosisMultiple Sclerosis International · 2021
  26. miRNA-Dependent CD4+ T Cell Differentiation in the Pathogenesis of Multiple SclerosisMultiple Sclerosis International · 2021
  27. Teriflunomide Safety and Efficacy in Advanced Progressive Multiple SclerosisMultiple Sclerosis International · 2020
  28. Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MSMultiple Sclerosis International · 2020
  29. Evaluation of Lower Urinary Tract Dysfunction Impact on Quality of Life in Multiple Sclerosis Patients: Russian Translation and Validation of SF-QualiveenMultiple Sclerosis International · 2020
  30. Changes in Amino Acid and Acylcarnitine Plasma Profiles for Distinguishing Patients with Multiple Sclerosis from Healthy ControlsMultiple Sclerosis International · 2020
  31. Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple SclerosisMultiple Sclerosis International · 2020
  32. Integrating Caregiver Support into Multiple Sclerosis CareMultiple Sclerosis International · 2020
  33. Biofeedback Based Home Balance Training can Improve Balance but Not Gait in People with Multiple SclerosisMultiple Sclerosis International · 2019
  34. Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR ImagingMultiple Sclerosis International · 2019
  35. A Pilot Study to Assess At-Home Speed of Processing Training for Individuals with Multiple SclerosisMultiple Sclerosis International · 2019
  36. Repeated Working Memory Training Improves Task Performance and Neural Efficiency in Multiple Sclerosis Patients and Healthy ControlsMultiple Sclerosis International · 2019
  37. Real-Life Outcome in Multiple Sclerosis in the Czech RepublicMultiple Sclerosis International · 2019
  38. Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of UseMultiple Sclerosis International · 2019
  39. Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic ResponsesMultiple Sclerosis International · 2018
  40. The Role of Wearable Devices in Multiple SclerosisMultiple Sclerosis International · 2018
  41. Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological QuestionnaireMultiple Sclerosis International · 2018
  42. Dealing with Chronic Illness: Experiences of Iranian Families of Persons with Multiple Sclerosis—A Qualitative StudyMultiple Sclerosis International · 2017
  43. The Effects of Aerobic Exercise on the Recovery of Walking Ability and Neuroplasticity in People with Multiple Sclerosis: A Systematic Review of Animal and Clinical StudiesMultiple Sclerosis International · 2017
  44. Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future PerspectivesMultiple Sclerosis International · 2017
  45. Depression Treatment among Adults with Multiple Sclerosis and Depression in Ambulatory Care Settings in the United StatesMultiple Sclerosis International · 2017
  46. The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and PrognosisMultiple Sclerosis International · 2017
  47. The Incidence of Euphoria in Multiple Sclerosis: Artefact of MeasureMultiple Sclerosis International · 2016
  48. Healthy Aging from the Perspectives of 683 Older People with Multiple SclerosisMultiple Sclerosis International · 2016
  49. Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksMultiple Sclerosis International · 2016
  50. The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis: A Pilot StudyMultiple Sclerosis International · 2016